I may not be a doctor, but as of January 2022, 16 months before the first RSV vaccine was approved, these vaccinations could make children more seriously ill from the virus. I was warning. The industry has been unsuccessful in producing an RSV vaccine for decades, since the program was canceled in 1967 because it caused enhanced antibody-dependent disease.
Now, as problems persist with the first RSV vaccines from Pfizer and GSK, the FDA has acknowledged that Moderna's mRNA version is causing severe RSV cases in children. It's time for the next Department of Health and Human Services to join state officials in moving away from both RSV vaccination and all types of mRNA vaccines.
We have too much public information to sustain this deception any longer. The time to take action on this longstanding failure is January 20th, not one day later.
of
FDA reports Last week, at least five cases of severe or very severe RSV occurred in infants who received Moderna's new mRNA vaccine during clinical trials. The Biden administration has already approved Pfizer and GSK's senior respiratory syncytial virus vaccine, Pfizer's infant vaccine, and a monoclonal antibody treatment for young children, all of which have documented safety concerns. Earlier this year, the government approved an mRNA version of Moderna for older adults (mRESVIA).
However, the FDA has now clarified that infant enrollment in clinical trials is “pending for all clinical studies of RSV vaccine candidates” under the U.S. Investigational New Drug Protocol.
Clinical trials have shown shocking results. “The rate of severe disease was 26.3% in the vaccine group, compared to 8.3% in the placebo group.'' Let's talk about “the more you inject, the more contagious you are''! If infants are having so many problems, why are we giving this vaccine to other people, especially older adults who, unlike the flu or coronavirus, are not at significant risk from RSV?
Moderna used two versions of its vaccine in clinical trials, one of which, mRNA-1345 (mRESVIA), induced severe RSV in infants. This same vaccine is now being given to older people.
Why do we continue to promote RSV vaccination, given 60-year-old concerns about worsening the disease? Despite the documented problems with COVID-19 vaccination, why do we continue to promote RSV vaccination? Will we continue to approve vaccines? Why approve Pfizer's RSV vaccine for pregnant women when GSK's nearly identical version has been approved?
extracted from clinical trials What happens after a fatal accident?
Finally, why are we promoting vaccines for respiratory viruses in the first place? COVID-19 and influenza are respiratory viruses.
doesn't respond well It affects blood-based antibodies, often leading to immune imprinting and increasing the risk of infection in the long term.
These are simple questions that even a layperson can understand, yet medical professionals are still stuck in ignorance and greed.
greater risk to baby
Pfizer and Moderna's new coronavirus vaccine clinical trial for infants
revealed Leaky respiratory virus vaccines mean that the risk of respiratory viruses tends to increase rather than decrease. in Moderna lawsuit Researchers found a statistically significant increase in respiratory viruses within 28 days of vaccination in infants aged 6 to 23 months.
For croup, 1.3% of mRNA-1273 recipients were infected compared to only 0.3% of placebo recipients. For RSV, the infection rate was 0.8% in mRNA-1273 recipients and 0.5% in the placebo group. Pneumonia occurred in 0.2% of those receiving mRNA-1273, compared to none in the placebo group.
In Moderna's trial of children ages 2 to 5, 0.3% of participants developed pneumonia, compared to none who received a placebo. For RSV, the rate was 0.4% in vaccinated children and less than 0.1% in the placebo group. In other words, young children in the vaccinated group
4 times more likely They were more likely to become infected with RSV within 4 weeks after vaccination than those in the placebo group.
This trend persisted even among 6- to 11-year-olds, who are less susceptible to RSV infection. In that group, 0.3% of vaccine recipients experienced illness, compared to zero in the placebo group.
Pfizer infant pediatric vaccine clinical trial (
See page 51) also recorded serious adverse events including RSV bronchiolitis (5 participants), pneumonia (2 participants), gastroenteritis (2 participants), and lower respiratory tract infections (2 participants). I did.
Apparently, respiratory virus vaccines make individuals more vulnerable to RSV. Although many people are currently avoiding these vaccines, the industry is employing clever marketing strategies. It offers monoclonal antibodies as a preventive measure against RSV, alongside the GSK, Pfizer and Moderna vaccinations. Bayfortas (nilsevimab), originally developed by AstraZeneca and now marketed by Sanofi, has been given to newborns since October last year. New mothers are convinced that their babies can suddenly die from respiratory syncytial virus. RSV may have originated in the 1950s.
Polio vaccine research. According to the CDC: 40.5% of babies In America, we received Bay Fortus during the last RSV season.
The FDA briefing document on Moderna's clinical trial reported that not only did Moderna's vaccination make the disease worse, but Bayfortas' effectiveness in infants who received both vaccines was “slowed down.” But what the report doesn't make clear is that Beyfortus is just as problematic as Moderna's mRESVIA.
After hundreds of thousands of French babies receive Beyfortas in 2023, Dr. Helene Banoun
Shocking and unexplained increase Infant deaths associated with vaccine uptake. Professor Banoon also highlighted the FDA's own data, which he said clearly, and surprisingly, showed a much higher mortality rate in the Beyfortas treatment group compared to the placebo. This data can be found on page 70 of this book. Biological products license application Beyfortus article, but the manufacturer seems to be relying on no one reading it.
Other literature cited in the Banoon paper shows that children are becoming more seriously ill with respiratory illnesses, and that this is due to immune imprinting and disease, a negative effect on the very diseases that vaccines are supposed to treat. This suggests an increase in
According to the VAERS report,
The baby boy died soon after. The baby girl was found unresponsive seven hours after receiving the injection. It's called “sudden infant death syndrome.”
What Trump Can Do
Moreover, the problem goes beyond the individuals receiving the vaccine. Dr Peter McCullough records:
growing evidence It is possible that these products are creating super-resistant strains of RSV.
As a civilization, we cannot continue like this. Based on the available data, continuing mass vaccination without immediate restrictions or research violates the principles of the pro-life movement. It also violates the Nuremberg Laws on human experimentation.
To that end, Trump's next Secretary of Health and Human Services would do well to implement the following policies regarding vaccines.
- If it is not proven to prevent infection, it should not be sold as a vaccine in any form.
- No vaccination should be approved without a complete placebo group kept permanently to study long-term differences from the trial group.
- Vaccination should not be approved unless long-term improvements in all-cause mortality are shown, and unless there is a clear demonstration of an increase in deaths in the trial group.
- If there are clear safety signals in other age groups, vaccination should not be authorized for a given age group unless it can be demonstrated that these safety issues do not apply to the target cohort. For example, even after the FDA acknowledged that RSV injections caused Guillain-Barre syndrome; withdrew approval For people over the age of 60, the agency has not yet This shot is recommended for people over 75 years old.
- There are no mRNA shots.
- Without carcinogenicity, genotoxicity, or long-term safety studies, no vaccination should be approved and no RSV vaccination has been conducted.
This issue is no longer just about COVID-19 or Operation Warp Speed. Approval of the RSV vaccine was done publicly, as in 1967, despite known problems with these vaccinations from day one. We didn't even have to rely on emergency use authorization.
We have too much public information to sustain this deception any longer. The time to act on this longstanding failure is January 20th, not one day later.
